Papers
7
Total Citations
83
H-Index
5
About
Dr. Xianzhong Deng is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for prostate cancer and benign prostatic hyperplasia (BPH). His major contributions lie in conducting rigorous systematic reviews and meta-analyses that compare emerging robotic and laser technologies against established approaches. Notably, his 2021 meta-analysis on single-port versus multiport robot-assisted radical prostatectomy (33 citations) provided crucial evidence on the comparative safety and oncologic outcomes of the SP robot, helping guide surgical decision-making. Dr. Deng has also clarified the role of nerve-sparing techniques in high-risk prostate cancer, demonstrating through a 2023 meta-analysis (20 citations) that neurovascular bundle preservation can be safely performed without compromising oncologic control. His work extends to BPH, where he has compared thulium laser enucleation and holmium laser enucleation against robotic prostatectomy, as well as to gynecologic cancers and adrenal surgery. With over 80 total citations across his most-cited papers, Dr. Deng’s evidence-based analyses have become essential references for urologists navigating the rapidly evolving landscape of robotic and laser surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7